Another finding: Many people with HIV prefer using the injectable medication to taking daily pills.
Supporters of people with HIV/AIDS rallied at the IDWeek 2026 conference in Washington, DC.
A new study finds that the pause in funding led to a drop in HIV testing, prevention, and treatment.
A dozen infectious pathogens contribute to cancer. Finding ways to prevent them could help millions avoid a cancer diagnosis.
Teens taking daily HIV pills are more likely to have a viral rebound than those on injectable antiretroviral therapy.
An estimated $1.35 billion for TB, HIV, malaria, and maternal and child health is set to expire on September 30.
1 in 60 adults in Fiji is HIV-positive.
In a phase 3 clinical trial, a once-weekly oral HIV treatment maintained viral suppression as effectively as a standard once-daily regimen.
Donor government funding for the global HIV response fell by $2.1 billion in 2025, a decline driven by the US government.
A new work requirement rule goes into effect in January. Experts anticipate higher rates of HIV transmission.
